A porous silicon immunoassay platform for fluorometric determination of α-synuclein in human cerebrospinal fluid

Improved porous silicon microarray based prostate specific antigen immunoassay by optimized surface density of the capture antibody

(2013) SangWook Lee et al.   ANALYTICA CHIMICA ACTA

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

(2012) Sara Hall et al.   ARCHIVES OF NEUROLOGY

Porous silicon antibody microarrays for quantitative analysis: Measurement of free and total PSA in clinical plasma samples

(2012) Kerstin Järås et al.   CLINICA CHIMICA ACTA

α-Synuclein in Parkinson disease and other neurodegenerative disorders

(2011) Michael Eller et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

(2010) Zhen Hong et al.   BRAIN

Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome

(2010) M.B. Aerts et al.   MOVEMENT DISORDERS

Detection of elevated levels of  -synuclein oligomers in CSF from patients with Parkinson disease

(2010) T. Tokuda et al.   NEUROLOGY

Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

(2008) Brit Mollenhauer et al.   EXPERIMENTAL NEUROLOGY